Please assess the completion status of the following clinical trial:

Trial Title: LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with stable ischemic heart disease or ACS undergoing cardiac catheterization and possible PCI of a culprit lesion~* The study patient or the study patient's legal representative has been informed of the nature of the study, agrees to its provisions and has provided written informed consent approved by the Institutional Review Board.~* The study patient agrees to comply with all required post-procedure follow up.~* Patient age 18-89 years old~Exclusion Criteria:~* STEMI within the prior 24 hours~* Cardiogenic shock or hypotension needing inotropes or hemodynamic support device~* Intra-procedural complication (perforation or a complication that would necessitate immediate-unplanned revascularization) during index PCI procedure~* History of CABG~* Subject life expectancy less than 2 years at time of index catheterization~* Pregnant or unknown pregnancy status~* Psychological unsuitability or extreme claustrophobia~* Currently participating in another investigational cardiac device study. Note: Trials requiring extended follow-up for products that were investigational, but have since become commercially available, are not considered investigational trials~* Inability to tolerate beta blockers~* Atrio-ventricular block (grade II-III), prolonged QT interval or sick sinus syndrome~* Renal insufficiency (creatinine ≥ 1.6 and/or, GFR \< 60 ml/min) or renal failure requiring dialysis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cardiac Catheterization with NIRS/IVUS (Type: None): Cardiac cathetirization with NIRS/IVUS assessment if with blockage of indeterminate severity (greater or equal to 20% to 70%). One day to one week after invasive catheterization a CCTA will be done to correlate result, then CCTA will be repeated at 24 months

Based on this trial design, predict the completion outcome and termination type (if applicable).